Small interfering RNA against transcription factor STAT6 leads to increased cholesterol synthesis in lung cancer cell lines

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Dubey, Richa ^a   Chhabra, Ravindresh ^a   Saini, Neeru ^a  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; RNA; SMALL INTERFERING RNA; STAT6 PROTEIN; FORKHEAD TRANSCRIPTION FACTOR; FOXJ2 PROTEIN, HUMAN; LIPOCORTIN 5;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; LUNG CANCER; NUCLEOTIDE SEQUENCE; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; APOPTOSIS; BIOLOGY; CARCINOMA; CHEMISTRY; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; LUNG TUMOR; METABOLISM; METHODOLOGY; PROMOTER REGION; TUMOR CELL LINE;

ANNEXIN A5; APOPTOSIS; CARCINOMA; CELL LINE, TUMOR; CHOLESTEROL; COMPUTATIONAL BIOLOGY; DOWN-REGULATION; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; LUNG NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS, GENETIC; RNA, SMALL INTERFERING; STAT6 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC;

EID: 82655180427     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028509     Document Type: Article

References (47)

1. Baus D, Nonnenmacher F, Jankowski S, Doring C, Brautigam C, et al. (2009) STAT6 and STAT1 are essential antagonistic regulators of cell survival in classical Hodgkin lymphoma cell line. Leukemia 23: 1885-1893.
2. Zhu J, Guo L, Watson CJ, Hu-Li J, Paul WE, (2001) Stat6 is necessary and sufficient for IL-4's role in Th2 differentiation and cell expansion. J Immunol 166: 7276-7281.
3. Li BH, Yang XZ, Li PD, Yuan Q, Liu XH, et al. (2008) IL-4/Stat6 activities correlate with apoptosis and metastasis in colon cancer cells. Biochem Biophys Res Commun 369: 554-560.
4. Zhang M, Zhou Y, Xie C, Zhou F, Chen Y, et al. (2006) STAT6 specific shRNA inhibits proliferation and induces apoptosis in colon cancer HT-29 cells. Cancer Lett 243: 38-46.
5. Darnell JE Jr, Kerr IM, Stark GR, (1994) Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264: 1415-1421.
6. Schindler C, Darnell JE Jr, (1995) Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem 64: 621-651.
7. Hebenstreit D, Wirnsberger G, Horejs-Hoeck J, Duschl A, (2006) Signaling mechanisms, interaction partners, and target genes of STAT6. Cytokine Growth Factor Rev 17: 173-188.
8. Takeda K, Tanaka T, Shi W, Matsumoto M, Minami M, et al. (1996) Essential role of Stat6 in IL-4 signalling. Nature 380: 627-630.
9. Takeda K, Kamanaka M, Tanaka T, Kishimoto T, Akira S, (1996) Impaired IL-13-mediated functions of macrophages in STAT6-deficient mice. J Immunol 157: 3220-3222.
10. Kaplan MH, Schindler U, Smiley ST, Grusby MJ, (1996) Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4: 313-319.
11. Shimoda K, van Deursen J, Sangster MY, Sarawar SR, Carson RT, et al. (1996) Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380: 630-633.
12. Jaruga B, Hong F, Sun R, Radaeva S, Gao B, (2003) Crucial role of IL-4/STAT6 in T cell-mediated hepatitis: up-regulating eotaxins and IL-5 and recruiting leukocytes. J Immunol 171: 3233-3244.
13. Kato A, Yoshidome H, Edwards MJ, Lentsch AB, (2000) Reduced hepatic ischemia/reperfusion injury by IL-4: potential anti-inflammatory role of STAT6. Inflamm Res 49: 275-279.
14. Low SH, Vasanth S, Larson CH, Mukherjee S, Sharma N, et al. (2006) Polycystin-1, STAT6, and P100 function in a pathway that transduces ciliary mechanosensation and is activated in polycystic kidney disease. Dev Cell 10: 57-69.
15. Yu HH, Liu PH, Lin YC, Chen WJ, Lee JH, et al. (2010) Interleukin 4 and STAT6 gene polymorphisms are associated with systemic lupus erythematosus in Chinese patients. Lupus 19: 1219-1228.
16. Shum BO, Mackay CR, Gorgun CZ, Frost MJ, Kumar RK, et al. (2006) The adipocyte fatty acid-binding protein aP2 is required in allergic airway inflammation. J Clin Invest 116: 2183-2192.
17. Iff J, Wang W, Sajic T, Oudry N, Gueneau E, et al. (2009) Differential proteomic analysis of STAT6 knockout mice reveals new regulatory function in liver lipid homeostasis. J Proteome Res 8: 4511-4524.
18. Das S, Roth CP, Wasson LM, Vishwanatha JK, (2007) Signal transducer and activator of transcription-6 (STAT6) is a constitutively expressed survival factor in human prostate cancer. Prostate 67: 1550-1564.
19. Cui X, Zhang L, Luo J, Rajasekaran A, Hazra S, et al. (2007) Unphosphorylated STAT6 contributes to constitutive cyclooxygenase-2 expression in human non-small cell lung cancer. Oncogene 26: 4253-4260.
20. Pfaffl MW, (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.
21. Edgar R, Domrachev M, Lash AE, (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30: 207-210.
22. Thomas PD, Campbell MJ, Kejariwal A, Mi H, Karlak B, et al. (2003) PANTHER: a library of protein families and subfamilies indexed by function. Genome Res 13: 2129-2141.
23. Hubbard TJ, Aken BL, Ayling S, Ballester B, Beal K, et al. (2009) Ensembl 2009. Nucleic Acids Res 37: D690-697.
24. Zheng J, Wu J, Sun Z, (2003) An approach to identify over-represented cis-elements in related sequences. Nucleic Acids Res 31: 1995-2005.
25. Pandey AK, Munjal N, Datta M, (2010) Gene expression profiling and network analysis reveals lipid and steroid metabolism to be the most favored by TNFalpha in HepG2 cells. PLoS One 5: e9063.
26. Yap YL, Lam DC, Luc G, Zhang XW, Hernandez D, et al. (2005) Conserved transcription factor binding sites of cancer markers derived from primary lung adenocarcinoma microarrays. Nucleic Acids Res 33: 409-421.
27. Blais A, Dynlacht BD, (2005) Constructing transcriptional regulatory networks. Genes Dev 19: 1499-1511.
28. Ni Z, Lou W, Lee SO, Dhir R, DeMiguel F, et al. (2002) Selective activation of members of the signal transducers and activators of transcription family in prostate carcinoma. J Urol 167: 1859-1862.
29. Zhang MS, Zhou YF, Zhang WJ, Zhang XL, Pan Q, et al. (2006) Apoptosis induced by short hairpin RNA-mediated STAT6 gene silencing in human colon cancer cells. Chin Med J (Engl) 119: 801-808.
30. King VL, Szilvassy SJ, Daugherty A, (2002) Interleukin-4 deficiency promotes gallstone formation. J Lipid Res 43: 768-771.
31. Black HES, NJ), (1993) Use of interleukin-4- for lowering blood-cholesterol levels. United States Schering Corporation (Kenilworth, NJ).
32. Aprahamian T, Bonegio R, Rizzo J, Perlman H, Lefer DJ, et al. (2006) Simvastatin treatment ameliorates autoimmune disease associated with accelerated atherosclerosis in a murine lupus model. J Immunol 177: 3028-3034.
33. Matsumoto M, Einhaus D, Gold ES, Aderem A, (2004) Simvastatin augments lipopolysaccharide-induced proinflammatory responses in macrophages by differential regulation of the c-Fos and c-Jun transcription factors. J Immunol 172: 7377-7384.
34. Kuperman D, Schofield B, Wills-Karp M, Grusby MJ, (1998) Signal transducer and activator of transcription factor 6 (Stat6)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production. J Exp Med 187: 939-948.
35. Akimoto T, Numata F, Tamura M, Takata Y, Higashida N, et al. (1998) Abrogation of bronchial eosinophilic inflammation and airway hyperreactivity in signal transducers and activators of transcription (STAT)6-deficient mice. J Exp Med 187: 1537-1542.
36. Darcan-Nicolaisen Y, Meinicke H, Fels G, Hegend O, Haberland A, et al. (2009) Small Interfering RNA against Transcription Factor STAT6 Inhibits Allergic Airway Inflammation and Hyperreactivity in Mice. Journal of Immunology 182: 7501-7508.
37. Fessler MB, Massing MW, Spruell B, Jaramillo R, Draper DW, et al. (2009) Novel relationship of serum cholesterol with asthma and wheeze in the United States. J Allergy Clin Immunol 124: 967-974 e961-915.
38. Perez-Sanchez C, Gomez-Ferreria MA, de La Fuente CA, Granadino B, Velasco G, et al. (2000) FHX, a novel fork head factor with a dual DNA binding specificity. J Biol Chem 275: 12909-12916.
39. Kaufmann E, Knochel W, (1996) Five years on the wings of fork head. Mech Dev 57: 3-20.
40. Gomez-Ferreria MA, Rey-Campos J, (2003) Functional domains of FOXJ2. J Mol Biol 329: 631-644.
41. Martin-de-Lara F, Sanchez-Aparicio P, Arias de la Fuente C, Rey-Campos J, (2008) Biological effects of FoxJ2 over-expression. Transgenic Res 17: 1131-1141.
42. Guiter C, Dusanter-Fourt I, Copie-Bergman C, Boulland ML, Le Gouvello S, et al. (2004) Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma. Blood 104: 543-549.
43. Skinnider BF, Elia AJ, Gascoyne RD, Patterson B, Trumper L, et al. (2002) Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood 99: 618-626.
44. Oren M, (2003) Decision making by p53: life, death and cancer. Cell Death Differ 10: 431-442.
45. Meulmeester E, Jochemsen AG, (2008) p53: a guide to apoptosis. Curr Cancer Drug Targets 8: 87-97.
46. Bailey DP, Kashyap M, Mirmonsef P, Bouton LA, Domen J, et al. (2004) Interleukin-4 elicits apoptosis of developing mast cells via a Stat6-dependent mitochondrial pathway. Exp Hematol 32: 52-59.
47. Kaplan MH, Daniel C, Schindler U, Grusby MJ, (1998) Stat proteins control lymphocyte proliferation by regulating p27Kip1 expression. Mol Cell Biol 18: 1996-2003.